Correction to: Caplacizumab: First Global Approval
Crossref DOI link: https://doi.org/10.1007/s40265-018-1031-2
Published Online: 2018-12-03
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Duggan, Sean
Text and Data Mining valid from 2018-12-01
Article History
First Online: 3 December 2018